Latest filing published 22 May 2025 for Oncology Institute, Inc., €13k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jeremy Castle: trading record in brief
Jeremy Castle discloses dealings in Starling Oncology, Inc. to SEC (Form 4). In total, 6 filings cover trades dated from 30 November 2023 to 21 May 2025.
The open-market record is one-sided, with 1 purchase worth €8,745 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 share grants. In 2025 alone, the filings show 1 purchase and no sales.
On 22 May 2025 came the latest disclosure, a transaction for €13k in Starling Oncology, Inc. The last insider purchase was made public on 28 March 2025, 592 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeremy Castle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,636 shares@ US$2.67559.9% of flowCommon stockSEC:0001628280-25-027201:0
- 162,281 shares0Common stockSEC:0001799191-25-000019:0
- 9,056 shares@ US$1.041739.4% of flowCommon StockSEC:0001079973-25-000519:0Canonical exit: 24 Jun 2025 (T+90)
- 1,130 shares@ US$0.160.8% of flowCommon stockSEC:0001799191-24-000065:0
- 70,120 shares0Common StockSEC:0001799191-24-000008:0
- 12,340 shares0Common stockSEC:0001628280-23-040679:0
6 of 6 declarations
